Journal
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
Volume 107, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.msec.2019.110248
Keywords
3D printing; Stereolithography; Microneedles; Anticancer delivery; Tumour regression
Categories
Funding
- Wellcome Trust [WT094085MA]
Ask authors/readers for more resources
In this study, novel 3D printed polymeric microneedle arrays were fabricated for enhanced cisplatin delivery to A-431 epidermoid skin tumours for cancer treatment. The microneedles were built by selectively photo-polymerising consecutive layers of a biocompatible photopolymer resin using stereolithography (SLA), followed by coating of cisplatin formulations using inkjet dispensing on the needle surface. The printability via SLA was optimized to improve microneedle mechanical properties and optical coherence tomography analysis showed excellent piercing capacity of 3D printed microneedles to an 80% penetration depth. Franz cell diffusion studies revealed rapid cisplatin release rates of 80-90% within 1 h and in vivo evaluation with Balb/c nude mice presented sufficient cisplatin permeabilization with high anticancer activity and tumour regression. Histopathology analysis confirmed the tumour inhibition effect, showing demarcated lesions with thin fibrous capsules and necrotic cores. The use of 3D printed microneedles demonstrates the potential for in-vivo transdermal delivery of anticancer drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available